Exacerbation of inflammatory bowel disease (IBD).
Avoid combining sulfasalazine with traditional NSAIDs.
Source: G&G 14e · p1112
NSAID · Anti-inflammatory
Tenoxicam, like other nonselective COX inhibitors (traditional NSAIDs), primarily acts by inhibiting cyclooxygenase (COX) enzymes, which are responsible for prostaglandin (PG) generation from arachidonic acid. It inhibits both COX-1 and COX-2 isoforms. The inhibition of COX-2 mediated enhanced PG synthesis at the site of inflammation is considered the most important mechanism of its anti-inflammatory action.
Exacerbation of inflammatory bowel disease (IBD).
Avoid combining sulfasalazine with traditional NSAIDs.
Source: G&G 14e · p1112
Increased risk of nephrotoxicity.
Avoid concurrent use.
Source: KDT 7e · p746
Increased aminoglycoside levels and potential toxicity.
Monitor aminoglycoside levels and renal function; adjust dosage as needed.
Source: KDT 7e
Increased risk of gastrointestinal bleed.
Monitor for bleeding; consider alternative analgesics or gastroprotective agents.
Source: KDT 7e
Enhanced CNS toxicity, seizures reported.
Source: KDT 7e
Increased risk of gastrointestinal bleed.
Monitor for bleeding; consider gastroprotective agents or alternative analgesics.
Source: KDT 7e
Increased bleeding risk.
Exercise extra caution and monitor for signs of bleeding.
Source: G&G 14e
Increased risk of gastrointestinal bleed.
Monitor for bleeding; consider gastroprotective agents.
Source: KDT 7e
Increased nephrotoxicity.
Avoid concomitant use or monitor renal function closely.
Source: KDT 7e
Increased risk of gastrointestinal bleed.
Monitor for bleeding; consider gastroprotective agents or alternative analgesics.
Source: KDT 7e
Reduced effectiveness of ACE inhibitors. Marked hyperkalemia, potentially leading to cardiac arrhythmia.
Use with caution, especially in the elderly and in patients with hypertension, diabetes mellitus, or ischemic heart disease.
Source: G&G 14e · p836
Increased risk of gastrointestinal bleed.
Monitor for bleeding; consider gastroprotective agents or alternative analgesics.
Source: KDT 7e
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Katzung, BNF·Verified: 2026-05-10 · House clinical team